
Keywords: 3TC; Lamivudine; ABC; Abacavir; ARV; Antiretroviral; ATV; Atazanavir; AZT; Zidovudine; d4T; Stavudine; DRV; Darunavir; EFV; Efavirenz; FTC; Emtricitabine; L&D; Labor and delivery; LOQ; Limit of quantification; LPV; Lopinavir; M8; NFV hydroxy-tert-butylami